NEUROPACE INC's ticker is NPCE and the CUSIP is 641288105. A total of 41 filers reported holding NEUROPACE INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 1.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1,886 | -3.2% | 420 | 0.0% | 0.00% | – |
| Q1 2023 | $1,949 | +211.3% | 420 | 0.0% | 0.00% | – |
| Q4 2022 | $626 | -68.7% | 420 | 0.0% | 0.00% | – |
| Q3 2022 | $2,000 | 0.0% | 420 | 0.0% | 0.00% | – |
| Q2 2022 | $2,000 | -33.3% | 420 | 0.0% | 0.00% | – |
| Q1 2022 | $3,000 | -25.0% | 420 | 0.0% | 0.00% | – |
| Q4 2021 | $4,000 | -42.9% | 420 | 0.0% | 0.00% | -100.0% |
| Q3 2021 | $7,000 | -30.0% | 420 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $10,000 | – | 420 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KCK LTD. | 5,621,111 | $21,079,000 | 40.88% |
| Revelation Capital Management, LLC | 42,972 | $161,000 | 3.78% |
| Soleus Capital Management, L.P. | 2,334,003 | $8,753,000 | 1.19% |
| Orbimed Advisors | 4,012,281 | $15,046,000 | 0.28% |
| Opaleye Management Inc. | 116,324 | $436,000 | 0.18% |
| Nantahala Capital Management | 443,502 | $1,663,000 | 0.11% |
| Bellevue Group AG | 388,368 | $1,456,000 | 0.02% |
| Ergoteles LLC | 31,027 | $116,000 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 31,648 | $119,000 | 0.00% |
| Financial Advocates Investment Management | 10,000 | $38,000 | 0.00% |